Search This Blog

Wednesday, February 2, 2022

NovoCure upped to Outperform from Perform by Oppenheimer

 Target $98

https://finviz.com/quote.ashx?t=NVCR&ty=c&ta=1&p=d

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.